Published in Arch Dis Child on June 01, 2001
Influenza vaccination for immunocompromised patients: systematic review and meta-analysis from a public health policy perspective. PLoS One (2011) 1.00
Influenza-associated morbidity in children with cancer. Pediatr Blood Cancer (2008) 0.94
Immunogenicity of influenza vaccine in colorectal cancer patients. Cancer Res Treat (2013) 0.82
A prospective study of chemotherapy immunologic effects and predictors of humoral influenza vaccine responses in a pediatric oncology cohort. Influenza Other Respir Viruses (2012) 0.80
Safety of high dose trivalent inactivated influenza vaccine in pediatric patients with acute lymphoblastic leukemia. Pediatr Blood Cancer (2013) 0.77
Protecting pediatric oncology patients from influenza. Oncologist (2013) 0.76
Immunogenicity and clinical effectiveness of the trivalent inactivated influenza vaccine in immunocompromised children undergoing treatment for cancer. Cancer Med (2015) 0.75
Immunogenicity and safety of high-dose trivalent inactivated influenza vaccine compared to standard-dose vaccine in children and young adults with cancer or HIV infection. Vaccine (2016) 0.75
Influenza vaccine. Arch Dis Child (2003) 0.75
Guidelines on vaccinations in paediatric haematology and oncology patients. Biomed Res Int (2014) 0.75
Absolute lymphocyte count predicts the response to new influenza virus H1N1 vaccination in pediatric cancer patients. Clin Vaccine Immunol (2012) 0.75
Routine vaccinations and child survival: follow up study in Guinea-Bissau, West Africa. BMJ (2000) 5.42
Do parents understand immunizations? A national telephone survey. Pediatrics (2000) 2.82
Community respiratory virus infections among hospitalized adult bone marrow transplant recipients. Clin Infect Dis (1996) 2.12
Pulmonary mechanics in patients with respiratory muscle weakness. Am Rev Respir Dis (1977) 1.98
Influenza among hospitalized adults with leukemia. Clin Infect Dis (1997) 1.68
The orthopaedic aspects of spinal muscular atrophy. J Bone Joint Surg Am (1976) 1.47
Reactogenicity and immunogenicity of bivalent influenza vaccine in one- and two-dose trials in children: a summary. J Infect Dis (1977) 1.45
The immunosuppressive effects of long-term combination chemotherapy in children with acute leukemia in remission. Cancer Res (1971) 1.43
Influenza A virus infections among hospitalized adult bone marrow transplant recipients. Bone Marrow Transplant (1994) 1.42
REGIONAL LUNG FUNCTION IN KYPHOSCOLIOSIS. Thorax (1965) 1.33
Antibody response to a two-dose regimen of influenza vaccine in allogeneic T cell-depleted and autologous BMT recipients. Bone Marrow Transplant (1993) 1.17
Pulmonary function in progressive muscular dystrophy. Chest (1972) 1.16
Influenza in children with cancer. J Pediatr (1989) 1.14
Seroconversion after influenza vaccination in patients with lung cancer. Br J Cancer (1999) 1.08
Effects of posture and spinal bracing on respiratory function in neuromuscular disease. Arch Dis Child (1986) 1.03
Influenza in children and young adults with cancer: 20 cases. Cancer (1977) 1.01
Effect of cancer chemotherapy on the immune response to influenza virus vaccine: review of published studies. Rev Infect Dis (1985) 1.00
Epidemiology of influenza A virus infection in patients with acute or chronic leukemia. Support Care Cancer (1995) 1.00
Tidal breathing analysis and response to salbutamol in awake young children with and without asthma. Eur Respir J (1994) 0.97
Antibody response to a two-dose influenza vaccine regimen in adult lymphoma patients on chemotherapy. Eur J Clin Microbiol Infect Dis (1993) 0.96
Influenza A and the virus associated haemophagocytic syndrome: cluster of three cases in children with acute leukaemia. J Clin Pathol (1991) 0.95
Influenza immunization of children with neoplastic diseases. Cancer (1980) 0.95
Influenza immunization in immunosuppressed children. J Pediatr (1978) 0.94
Lung function in awake healthy infants: the first five days of life. Eur Respir J (1993) 0.93
Influenza: a shot or not? Pediatrics (1987) 0.92
Influenza surveillance in England and Wales: October 1995 to June 1996. Commun Dis Rep CDR Rev (1996) 0.92
Scoliosis in spinal muscular atrophy: natural history and management. Dev Med Child Neurol (1989) 0.92
Respiratory muscle strength and control of ventilation in patients with neuromuscular disease. Chest (1991) 0.91
Scoliosis in spinal muscular atrophy: review of 63 cases. J Child Neurol (1989) 0.90
Antigenicity and reactogenicity of influenza A/USSR/77 virus vaccine in children--a multicentered evaluation of dosage and safety. Rev Infect Dis (1983) 0.89
Zanamivir for influenza: a public health perspective. Its use will require careful management by GPs. BMJ (1999) 0.89
Immunogenicity of subunit trivalent influenza vaccine in children with acute lymphoblastic leukemia. Pediatr Infect Dis J (1998) 0.88
Antibody responses to influenza immunization of children with acute lymphoblastic leukemia. J Infect Dis (1979) 0.87
Response to influenza virus vaccine in children receiving chemotherapy for malignancy. J Pediatr (1978) 0.87
Lung function measurements in awake compared to sleeping newborn infants. Pediatr Pulmonol (1992) 0.86
Reactogenicity and immunogenicity of bivalent influenza A and monovalent influenza B virus vaccines in high-risk children. J Infect Dis (1977) 0.84
Respiratory function in handicapped children. Brain Dev (1990) 0.84
Child neuromuscular disease in southern Norway. Prevalence, age and distribution of diagnosis with special reference to "non-Duchenne muscular dystrophy". Clin Genet (1988) 0.84
Immunization against influenza in children with cancer: results of a three-dose trial. J Infect Dis (1982) 0.84
Kinetics of humoral response in children with acute lymphoblastic leukemia immunized with influenza vaccine in 1993 in Poland. Leuk Lymphoma (1997) 0.81
Bivalent influenza vaccine in children with cancer. J Infect Dis (1977) 0.81
Influenza surveillance in England and Wales: October 1996 to June 1997. Commun Dis Rep CDR Rev (1997) 0.79
Influenza immunization: time to stop the charade. Curr Opin Pediatr (1995) 0.77
Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction. Euro Surveill (2012) 7.96
Resistance to methicillin and other antibiotics in isolates of Staphylococcus aureus from blood and cerebrospinal fluid, England and Wales, 1989-95. Lancet (1997) 5.22
Severe respiratory illness caused by a novel coronavirus, in a patient transferred to the United Kingdom from the Middle East, September 2012. Euro Surveill (2012) 4.96
Detection of anti-H5 responses in human sera by HI using horse erythrocytes following MF59-adjuvanted influenza A/Duck/Singapore/97 vaccine. Virus Res (2004) 3.95
Neuraminidase sequence analysis and susceptibilities of influenza virus clinical isolates to zanamivir and oseltamivir. Antimicrob Agents Chemother (2003) 3.90
Evaluation of neuraminidase enzyme assays using different substrates to measure susceptibility of influenza virus clinical isolates to neuraminidase inhibitors: report of the neuraminidase inhibitor susceptibility network. J Clin Microbiol (2003) 2.92
Mortality in Barrett's esophagus: three decades of experience at a single center. Endoscopy (2012) 2.67
Risk factors for surgical site infection following caesarean section in England: results from a multicentre cohort study. BJOG (2012) 2.57
Adverse impact of surgical site infections in English hospitals. J Hosp Infect (2005) 2.51
Pandemic Influenza A (H1N1) 2009 and mortality in the United Kingdom: risk factors for death, April 2009 to March 2010. Euro Surveill (2010) 2.49
Virological analysis of fatal influenza cases in the United Kingdom during the early wave of influenza in winter 2010/11. Euro Surveill (2011) 2.40
Assessment of baseline age-specific antibody prevalence and incidence of infection to novel influenza A/H1N1 2009. Health Technol Assess (2010) 2.33
Device-related sources of bacteraemia in English hospitals--opportunities for the prevention of hospital-acquired bacteraemia. J Hosp Infect (2003) 2.33
Detection of influenza A(H3N2) virus in children with suspected mumps during winter 2014/15 in England. Euro Surveill (2015) 2.19
Outbreak of low pathogenicity H7N3 avian influenza in UK, including associated case of human conjunctivitis. Euro Surveill (2006) 2.08
The duration and magnitude of influenza epidemics: a study of surveillance data from sentinel general practices in England, Wales and the Netherlands. Eur J Epidemiol (1999) 2.06
Venous leg ulcers: a prognostic index to predict time to healing. BMJ (1992) 2.05
Chlamydia trachomatis in the United Kingdom: a systematic review and analysis of prevalence studies. Sex Transm Infect (2004) 2.05
Carboplatin pharmacokinetics in children: the development of a pediatric dosing formula. The United Kingdom Children's Cancer Study Group. J Clin Oncol (1993) 1.93
Changes in severity of 2009 pandemic A/H1N1 influenza in England: a Bayesian evidence synthesis. BMJ (2011) 1.85
Effectiveness of seasonal 2010/11 and pandemic influenza A(H1N1)2009 vaccines in preventing influenza infection in the United Kingdom: mid-season analysis 2010/11. Euro Surveill (2011) 1.84
Advances in electronic surveillance for healthcare-associated infections in the 21st Century: a systematic review. J Hosp Infect (2013) 1.79
Continued emergence and changing epidemiology of oseltamivir-resistant influenza A(H1N1)2009 virus, United Kingdom, winter 2010/11. Euro Surveill (2011) 1.76
Clinical relevance of laboratory-reported antibiotic resistance in acute uncomplicated urinary tract infection in primary care. J Antimicrob Chemother (2006) 1.64
Severe and unrecognised: pertussis in UK infants. Arch Dis Child (2003) 1.62
A randomized comparison of liposomal versus conventional amphotericin B for the treatment of pyrexia of unknown origin in neutropenic patients. Br J Haematol (1997) 1.59
Cisplatin ototoxicity in children: a practical grading system. Med Pediatr Oncol (1991) 1.56
Expression of desmin and myoglobin in rhabdomyosarcomas and in developing skeletal muscle. Histopathology (1989) 1.53
Improved cure rate in children with B-cell acute lymphoblastic leukaemia (B-ALL) and stage IV B-cell non-Hodgkin's lymphoma (B-NHL)--results of the UKCCSG 9003 protocol. Br J Cancer (1998) 1.48
Estimating influenza vaccine effectiveness using routinely collected laboratory data. J Epidemiol Community Health (2009) 1.48
Can food influence the absorption of methotrexate in children with acute lymphoblastic leukaemia? Lancet (1980) 1.46
Intensive consolidation chemotherapy for acute lymphoblastic leukaemia (UKALL X pilot study). Arch Dis Child (1987) 1.46
The molecular pathology of small round-cell tumours--relevance to diagnosis, prognosis, and classification. J Pathol (1996) 1.45
Low effectiveness of seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2014/15 mid-season results. Euro Surveill (2015) 1.44
Increase in diagnosed newly acquired hepatitis C in HIV-positive men who have sex with men across London and Brighton, 2002-2006: is this an outbreak? Sex Transm Infect (2007) 1.44
Outcome after relapse in an unselected cohort of children and adolescents with Ewing sarcoma. Med Pediatr Oncol (2003) 1.43
Duration of operation as a risk factor for surgical site infection: comparison of English and US data. J Hosp Infect (2006) 1.42
Cleanyourhands Campaign: a critique of the critique. J Hosp Infect (2007) 1.42
High-dose methylprednisolone sodium succinate as a single agent in relapsed childhood acute lymphoblastic leukaemia. Med Pediatr Oncol (1992) 1.39
Distribution and antimicrobial susceptibility patterns of Clostridium difficile PCR ribotypes in English hospitals, 2007-08. Euro Surveill (2008) 1.39
Emergence of influenza A H1N2 reassortant viruses in the human population during 2001. Virology (2002) 1.39
Association of circulating TNF-alpha and IL-6 with ageing and parkinsonism. Acta Neurol Scand (1999) 1.38
Bradyphrenia and parkinsonism. Age Ageing (1994) 1.38
Influenza types and patient population. Lancet (1995) 1.37
The significance of cagA(+) Helicobacter pylori in reflux oesophagitis. Gut (2001) 1.34
Vaccine effectiveness of 2011/12 trivalent seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: evidence of waning intra-seasonal protection. Euro Surveill (2013) 1.32
Uptake and impact of a new live attenuated influenza vaccine programme in England: early results of a pilot in primary school-age children, 2013/14 influenza season. Euro Surveill (2014) 1.32
Mortality reduction in cardiac anesthesia and intensive care: results of the first International Consensus Conference. Acta Anaesthesiol Scand (2011) 1.31
Cranial tibial thrust: a primary force in the canine stifle. J Am Vet Med Assoc (1983) 1.29
Population estimates of persons presenting to general practitioners with influenza-like illness, 1987-96: a study of the demography of influenza-like illness in sentinel practice networks in England and Wales, and in The Netherlands. Epidemiol Infect (2000) 1.28
Trochlear recession for correction of luxating patella in the dog. J Am Vet Med Assoc (1985) 1.27
Immunogenicity of vaccination against influenza, Streptococcus pneumoniae and Haemophilus influenzae type B in patients with multiple myeloma. Br J Cancer (2000) 1.26
Cranial tibial wedge osteotomy: a technique for eliminating cranial tibial thrust in cranial cruciate ligament repair. J Am Vet Med Assoc (1984) 1.25
A phase II study of ifosfamide in children with recurrent solid tumours. Cancer Chemother Pharmacol (1985) 1.24
Influenza surveillance in England and Wales: October 1999 to May 2000. Commun Dis Public Health (2000) 1.24
Pandemic (H1N1) 2009 influenza in the UK: clinical and epidemiological findings from the first few hundred (FF100) cases. Epidemiol Infect (2010) 1.23
Fat, fish, fish oil and cancer. Br J Cancer (1996) 1.21
A decade of change: tuberculosis in England and Wales 1988-98. Arch Dis Child (2003) 1.20
Can syndromic surveillance data detect local outbreaks of communicable disease? A model using a historical cryptosporidiosis outbreak. Epidemiol Infect (2006) 1.19
'MACHO' chemotherapy for stage IV B cell lymphoma and B cell acute lymphoblastic leukaemia of childhood. United Kingdom Children's Cancer Study Group (UKCCSG). Br J Haematol (1990) 1.17
An evaluation of nine commercial EIA kits for the detection of measles specific IgG. J Virol Methods (1997) 1.17
Comparative phenotypes in rhabdomyosarcomas and developing skeletal muscle. Histopathology (1990) 1.16
The rate of diagnosis and demography of pelvic inflammatory disease in general practice: England and Wales. Int J STD AIDS (1999) 1.15
Linking syndromic surveillance with virological self-sampling. Epidemiol Infect (2007) 1.14
An estimate of the contribution of HIV infection to the recent rise in tuberculosis in England and Wales. Thorax (2002) 1.12
Large outbreak of isoniazid-monoresistant tuberculosis in London, 1995 to 2006: case-control study and recommendations. Euro Surveill (2011) 1.11
Addisonian crisis presenting with a normal short tetracosactrin stimulation test. Postgrad Med J (1992) 1.11
Mortality reduction in cardiac anesthesia and intensive care: results of the first International Consensus Conference. HSR Proc Intensive Care Cardiovasc Anesth (2011) 1.11
Lung involvement in neuroblastoma: incidence and characteristics. Med Pediatr Oncol (1997) 1.10
Ototoxicity of high-dose cis-platinum in children. Med Pediatr Oncol (1988) 1.09
Use of a large general practice syndromic surveillance system to monitor the progress of the influenza A(H1N1) pandemic 2009 in the UK. Epidemiol Infect (2011) 1.09
Evaluation of disc diffusion and Etest for determining the susceptibility of Staphylococcus aureus to mupirocin. J Antimicrob Chemother (1998) 1.08
Parents' attitude towards the second dose of measles, mumps and rubella vaccine: a case-control study. Commun Dis Public Health (2003) 1.08
Seroconversion after influenza vaccination in patients with lung cancer. Br J Cancer (1999) 1.08
Balloon occlusion of the abdominal aorta during caesarean hysterectomy for placenta percreta. Anaesth Intensive Care (1995) 1.08
Treatment of nondysgerminomatous ovarian germ cell tumors: an analysis of 69 cases. Cancer (1999) 1.08
Relative values of the interventions of diversion and improved donor-arm disinfection to reduce the bacterial risk from blood transfusion. Vox Sang (2004) 1.07
Influenza A antigen exposure selects dominant Vbeta17+ TCR in human CD8+ cytotoxic T cell responses. Int Immunol (2001) 1.05
How should general practitioners investigate suspected urinary tract infection? Variations in laboratory-confirmed bacteriuria in South West England. Commun Dis Public Health (2004) 1.05
The epidemiology of influenza. Occup Med (Lond) (2002) 1.04
A new laboratory-based surveillance system (Respiratory DataMart System) for influenza and other respiratory viruses in England: results and experience from 2009 to 2012. Euro Surveill (2014) 1.02
Interphase fluorescence in situ hybridization detection of t(2;13)(q35;q14) in alveolar rhabdomyosarcoma--a diagnostic tool in minimally invasive biopsies. J Pathol (1996) 1.01
High-dose melphalan with autologous stem-cell rescue in metastatic rhabdomyosarcoma. J Clin Oncol (1999) 1.01
QFLU: new influenza monitoring in UK primary care to support pandemic influenza planning. Euro Surveill (2006) 1.01
Small bowel enterocyte abnormalities caused by methotrexate treatment in acute lymphoblastic leukaemia of childhood. J Clin Pathol (1981) 1.01
Influenza antiviral susceptibility monitoring activities in relation to national antiviral stockpiles in Europe during the winter 2006/2007 season. Euro Surveill (2007) 1.01
Relapsed intracranial ependymoma in children in the UK: patterns of relapse, survival and therapeutic outcome. Eur J Cancer (2009) 1.00
Is HIV incidence increasing in homo/bisexual men attending GUM clinics in England, Wales and Northern Ireland? Commun Dis Public Health (2004) 0.99
Phase I study of temozolomide in paediatric patients with advanced cancer. United Kingdom Children's Cancer Study Group. Br J Cancer (1998) 0.99
High-dose rapid schedule chemotherapy for disseminated neuroblastoma. Eur J Cancer (1992) 0.99
Rates of surgical site infection after hip replacement as a hospital performance indicator: analysis of data from the English mandatory surveillance system. Infect Control Hosp Epidemiol (2008) 0.99
National enhanced surveillance of meningococcal disease in England, Wales and Northern Ireland, January 1999-June 2001. Epidemiol Infect (2002) 0.99
Failed central nervous system prophylaxis in children with acute lymphoblastic leukaemia: treatment and outcome. Br J Haematol (1984) 0.98
National outbreak of Salmonella Enteritidis phage type 14b in England, September to December 2009: case-control study. Euro Surveill (2011) 0.98
Improved outcome in children with advanced stage B-cell non-Hodgkin's lymphoma (B-NHL): results of the United Kingdom Children Cancer Study Group (UKCCSG) 9002 protocol. Br J Cancer (2000) 0.98
Autologous bone marrow transplantation for childhood acute lymphoblastic leukaemia in second remission - long-term follow-up. Bone Marrow Transplant (2000) 0.98